BLEO-cell

Medicinal product

(Invented) name

BLEO-cell

Active substance (s)

Bleomicinas

Strength

15000 TV

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į pilvaplėvės ertmę, leisti į veną, leisti į raumenis, vartoti į naviką, leisti į krūtinplėvės ertmę, leisti į arteriją, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L01DC01, Bleomycin

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2021-05-04

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra	1 vnt.
Bleomicinas	15000 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106483	92584	1092584	flakonas	10 ml N1		Receptinis	LT/L/21/1515/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-05-04	Registruotas